HASHICORP INC-CL A (HCP) Fundamental Analysis & Valuation

NASDAQ:HCP • US4181001037

Current stock price

34.78 USD
-0.03 (-0.09%)
At close:
34.98 USD
+0.2 (+0.58%)
After Hours:

This HCP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. HCP Profitability Analysis

1.1 Basic Checks

  • In the past year HCP was profitable.
  • HCP had a positive operating cash flow in the past year.
  • In the past 5 years HCP always reported negative net income.
  • In the past 5 years HCP always reported negative operating cash flow.
HCP Yearly Net Income VS EBIT VS OCF VS FCFHCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M -250M

1.2 Ratios

  • HCP has a Return On Assets (-7.22%) which is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of -9.72%, HCP is in line with its industry, outperforming 49.82% of the companies in the same industry.
Industry RankSector Rank
ROA -7.22%
ROE -9.72%
ROIC N/A
ROA(3y)-15.33%
ROA(5y)-17.17%
ROE(3y)-20.37%
ROE(5y)-30.92%
ROIC(3y)N/A
ROIC(5y)N/A
HCP Yearly ROA, ROE, ROICHCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

  • HCP's Gross Margin of 82.09% is amongst the best of the industry. HCP outperforms 86.93% of its industry peers.
  • HCP's Gross Margin has been stable in the last couple of years.
  • HCP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.31%
GM growth 5Y-0.29%
HCP Yearly Profit, Operating, Gross MarginsHCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. HCP Health Analysis

2.1 Basic Checks

  • HCP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • HCP has more shares outstanding than it did 1 year ago.
  • HCP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HCP Yearly Shares OutstandingHCP Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
HCP Yearly Total Debt VS Total AssetsHCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • HCP has an Altman-Z score of 9.80. This indicates that HCP is financially healthy and has little risk of bankruptcy at the moment.
  • HCP has a Altman-Z score of 9.80. This is amongst the best in the industry. HCP outperforms 85.87% of its industry peers.
  • HCP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.8
ROIC/WACCN/A
WACC13.94%
HCP Yearly LT Debt VS Equity VS FCFHCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • HCP has a Current Ratio of 3.79. This indicates that HCP is financially healthy and has no problem in meeting its short term obligations.
  • HCP's Current ratio of 3.79 is amongst the best of the industry. HCP outperforms 81.63% of its industry peers.
  • A Quick Ratio of 3.79 indicates that HCP has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 3.79, HCP belongs to the best of the industry, outperforming 81.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.79
Quick Ratio 3.79
HCP Yearly Current Assets VS Current LiabilitesHCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. HCP Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 247.62% over the past year.
  • HCP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.30%.
  • The Revenue has been growing by 61.00% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)247.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%333.33%
Revenue 1Y (TTM)16.3%
Revenue growth 3Y40.14%
Revenue growth 5Y61%
Sales Q2Q%18.66%

3.2 Future

  • Based on estimates for the next years, HCP will show a very strong growth in Earnings Per Share. The EPS will grow by 118.92% on average per year.
  • HCP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.37% yearly.
EPS Next Y509.24%
EPS Next 2Y171.61%
EPS Next 3Y118.92%
EPS Next 5YN/A
Revenue Next Year16.96%
Revenue Next 2Y15.67%
Revenue Next 3Y15.37%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HCP Yearly Revenue VS EstimatesHCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
HCP Yearly EPS VS EstimatesHCP Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. HCP Valuation Analysis

4.1 Price/Earnings Ratio

  • HCP is valuated quite expensively with a Price/Earnings ratio of 112.19.
  • HCP's Price/Earnings is on the same level as the industry average.
  • HCP is valuated expensively when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 71.87, which means the current valuation is very expensive for HCP.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HCP is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.68, HCP is valued quite expensively.
Industry RankSector Rank
PE 112.19
Fwd PE 71.87
HCP Price Earnings VS Forward Price EarningsHCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • HCP's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 124.32
EV/EBITDA N/A
HCP Per share dataHCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • HCP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as HCP's earnings are expected to grow with 118.92% in the coming years.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y171.61%
EPS Next 3Y118.92%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HCP Dividend Analysis

5.1 Amount

  • No dividends for HCP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

HCP Fundamentals: All Metrics, Ratios and Statistics

HASHICORP INC-CL A

NASDAQ:HCP (2/26/2025, 8:00:01 PM)

After market: 34.98 +0.2 (+0.58%)

34.78

-0.03 (-0.09%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-06
Earnings (Next)05-28
Inst Owners79.69%
Inst Owner Change0%
Ins Owners3.97%
Ins Owner Change0%
Market Cap7.11B
Revenue(TTM)654.89M
Net Income(TTM)-122.22M
Analysts52
Price Target35.32 (1.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1179.36%
Min EPS beat(2)163.27%
Max EPS beat(2)2195.45%
EPS beat(4)4
Avg EPS beat(4)814.28%
Min EPS beat(4)163.27%
Max EPS beat(4)2195.45%
EPS beat(8)8
Avg EPS beat(8)447.11%
EPS beat(12)12
Avg EPS beat(12)310.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.35%
Min Revenue beat(2)3.98%
Max Revenue beat(2)4.72%
Revenue beat(4)4
Avg Revenue beat(4)3.95%
Min Revenue beat(4)3.32%
Max Revenue beat(4)4.72%
Revenue beat(8)8
Avg Revenue beat(8)3.78%
Revenue beat(12)12
Avg Revenue beat(12)5.75%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.2%
EPS NQ rev (1m)-2.58%
EPS NQ rev (3m)22.03%
EPS NY rev (1m)0%
EPS NY rev (3m)42.14%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)1.25%
Revenue NY rev (1m)-0.24%
Revenue NY rev (3m)1.53%
Valuation
Industry RankSector Rank
PE 112.19
Fwd PE 71.87
P/S 10.86
P/FCF 124.32
P/OCF 104.53
P/B 5.65
P/tB 5.75
EV/EBITDA N/A
EPS(TTM)0.31
EY0.89%
EPS(NY)0.48
Fwd EY1.39%
FCF(TTM)0.28
FCFY0.8%
OCF(TTM)0.33
OCFY0.96%
SpS3.2
BVpS6.15
TBVpS6.05
PEG (NY)0.22
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.22%
ROE -9.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.09%
FCFM 8.73%
ROA(3y)-15.33%
ROA(5y)-17.17%
ROE(3y)-20.37%
ROE(5y)-30.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.31%
GM growth 5Y-0.29%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 84.44%
Cap/Sales 1.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.79
Quick Ratio 3.79
Altman-Z 9.8
F-Score6
WACC13.94%
ROIC/WACCN/A
Cap/Depr(3y)195.54%
Cap/Depr(5y)361.24%
Cap/Sales(3y)2%
Cap/Sales(5y)2.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)247.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%333.33%
EPS Next Y509.24%
EPS Next 2Y171.61%
EPS Next 3Y118.92%
EPS Next 5YN/A
Revenue 1Y (TTM)16.3%
Revenue growth 3Y40.14%
Revenue growth 5Y61%
Sales Q2Q%18.66%
Revenue Next Year16.96%
Revenue Next 2Y15.67%
Revenue Next 3Y15.37%
Revenue Next 5YN/A
EBIT growth 1Y37.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year118.63%
EBIT Next 3Y44.51%
EBIT Next 5YN/A
FCF growth 1Y156.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y173.12%
OCF growth 3YN/A
OCF growth 5YN/A

HASHICORP INC-CL A / HCP Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HASHICORP INC-CL A (HCP) stock?

ChartMill assigns a fundamental rating of 5 / 10 to HCP.


Can you provide the valuation status for HASHICORP INC-CL A?

ChartMill assigns a valuation rating of 3 / 10 to HASHICORP INC-CL A (HCP). This can be considered as Overvalued.


How profitable is HASHICORP INC-CL A (HCP) stock?

HASHICORP INC-CL A (HCP) has a profitability rating of 2 / 10.


Can you provide the financial health for HCP stock?

The financial health rating of HASHICORP INC-CL A (HCP) is 8 / 10.


What is the expected EPS growth for HASHICORP INC-CL A (HCP) stock?

The Earnings per Share (EPS) of HASHICORP INC-CL A (HCP) is expected to grow by 509.24% in the next year.